Stay updated on Waters Corporation Press Releases
Sign up to get notified when there's something new on the Waters Corporation Press Releases page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FTZdSNe-hxc4Ze1zqNa35Sr1FHWc.uncropped.jpg&w=3840&q=75)
Latest updates to the Waters Corporation Press Releases page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check4 days agoChange DetectedA new addition highlights the Waters New Rapid Screening-DSC, which significantly enhances thermal stability testing for antibody drugs, while the previous entry about the Waters ACQUITY QDa II Mass Detector has been removed.SummaryDifference99%
- Check5 days agoNo Change Detected
- Check24 days agoChange DetectedThe value on the web page has changed from June 3, 2024 to July 2, 2024. This change represents an update in the scheduling of the Second Quarter 2024 Earnings Conference Call by Waters Corporation.SummaryDifference95%
- Check54 days agoChange DetectedThe change on the webpage indicates that Waters Corporation has set new standards for high resolution performance and speed with the Xevo MRT Mass Spectrometer on June 3. Additionally, they have become the first liquid chromatography column provider to receive My Green Lab ACT Ecolabel Certification on the same date.SummaryDifference91%
- Check74 days agoChange DetectedThe value 8 ACQUITY QDa II Mass Detector Delivers Wider Range of Chemical Analysis within Cost-Effective, Lower Energy Instrument has been updated to 13 Corporation to Present at the Jefferies 2024 Healthcare Conference. This change indicates a shift in focus from product updates to corporate participation in industry events.SummaryDifference91%
- Check80 days agoChange DetectedThe value April 22 Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns has been replaced by May 7 Corporation (NYSE: WAT) Reports First Quarter 2024 Financial Results. This change likely represents an update on the financial performance and activities of the company, possibly related to investor relations or quarterly financial reporting.SummaryDifference96%
- Check94 days agoChange DetectedThe value '11 Corporation Schedules First Quarter 2024 Earnings Conference Call' has been updated to '22 Accelerates the Development of Gene-based Therapeutics with New GTxResolve Premier SEC Columns'. This change likely reflects an important update regarding the company's advancements in gene-based therapeutics and may be of interest to investors or stakeholders monitoring the company's progress.SummaryDifference97%
Stay in the know with updates to Waters Corporation Press Releases
Enter your email address, and we'll notify you when there's something new on the Waters Corporation Press Releases page.